Train Blast in Quetta Injures Dozens Raises Security Concerns for Pakistans Transport Sector Chinas Crypto Crackdown Faces Growing Challenges from Underground Middlemen SpaceXs Starlink Emerges as Core Growth Driver Ahead of Potential Nasdaq Listing Albertas Separation Referendum Potential Economic Implications for Canada and Energy Sector Fed Dissenters Explain No Votes Over Signaling Next Move Could Be a Cut Professional Title Morgan Stanley Cuts Home Depot Price Target by 20 Amid Housing Headwinds SCM Q1 2026 Earnings EPS Misses Estimates as Portfolio Pressures Emerge MSDL Q1 2026 Earnings Small EPS Beat Meets Modest Market Pullback RPAY Q1 2026 Earnings EPS Beat Drives 418 Stock Rally Despite Missing Revenue Details SPH Q1 2026 Earnings EPS Surpasses Estimates as Propane Demand Holds Steady SYF Q1 2026 Earnings Earnings Beat as Credit Quality Remains Resilient Precision Optics Corporation POCI Edges Lower Testing Key Support at 468 BDCI Holds Steady at 1003 Consolidation Signals for BTC Development Corp Invesco California Value Municipal Income Trust VCV Edges Higher Amid Steady Trading Helen of Troy Limited HELE Jumps 6 as Stock Tests Key Resistance at 2968 Real Messenger Corporation RMSG Holds Near Support Amid Modest Decline Liberty Broadband Corporation Class C LBRDK Q3 2025 Earnings Strong Profit Beat Drives Positive Market Reaction SpaceX IPO Opens to Retail Investors as Major Brokerages Democratize Access Understanding HELOCs A Flexible Home Equity Borrowing Option CXAI Q4 2025 Earnings EPS Miss Yet Shares Surge 12 on Strategic Progress SP 500 Treads Water as Technical Sell Signals Flash Amid Nvidia Earnings Hype HLX Q1 2026 Earnings Earnings Miss Weighs on Shares as Helix Energy Posts WiderThanExpected Loss Great Britain Retail Sales Fall 13 in April as Fuel Purchases See Sharpest Drop Since Pandemic IP Q1 2026 Earnings Earnings Beat Expectations with 338 Surprise BlackRock BLK Edges Higher Navigating Key Resistance Levels in a Volatile Market Transdigm Group TDG Q1 2026 Earnings EPS Surpasses Estimates as Core Markets Remain Strong YHGJ Q4 2023 Earnings Positive EPS Lifts Stock Despite Sparse Data Telomir Pharmaceuticals Q4 2025 Earnings Wider Than Expected Loss Highlights ClinicalStage Challenges PYXS Q1 2026 Earnings BetterthanExpected Loss Highlights Progress in Oncology Pipeline KLXE Q1 2026 Earnings EPS Beats Estimates Amid Sector Headwinds ASND Q1 2026 Earnings Wide EPS Miss as Ascendis Pharma Remains PreRevenue Stock Edges Higher NATR Q1 2026 Earnings Strong EPS Beat Hints at Profitability Gains